InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,930.80
(
0.19%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.21
(
-0.58%
)
Bitcoin
57,886.78
(
-0.23%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Pre_Clinical

Send PM Follow Ignore
Followers 4
Posts 145
Boards Moderated 0
Alias Born 05/11/2007

Pre_Clinical

Re: DewDiligence post# 4673

Thursday, 08/16/2007 5:04:43 PM

Thursday, August 16, 2007 5:04:43 PM

Post# of 19309

Plasma-derived antithrombin is already approved for DIC/sepsis in Japan and some European countries, but I guess that’s a detail that wasn’t consistent with your message.

And I would refer you to the Kybersept study which showed that AT3 failed in its clinical trial and showed an additional risk of hemorrhage. Please stop now. I dont feel like getting into a dragged out debate about sepsis. Thanks, Dew.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up